Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Little Rock, Arkansas 72205


Purpose:

The researchers want to find out if subjects treated on this study will achieve long term bone marrow recovery (engraftment) and if their tumors will respond to this treatment.


Criteria:

Inclusion Criteria: - Patients with advanced hematological malignancies who have failed at least two lines of therapy. - Karnofsky performance score > 60, unless due to disease and then > 50. - Age > 18 years. - An expected survival of > 3 months. - Subjects must have signed an IRB-approved consent and been informed about the investigational nature of the study. - Cord blood must have negative serology for HIV. - Release of cord blood. - The nucleated cell count of the CBU shall equal or exceed 1 x 107 per kg of recipient body weight. Exclusion Criteria: - Liver function: total bilirubin > 2x ULN or AST/ALT > 3x ULN. - Creatinine > 3.0 mg/dL.


NCT ID:

NCT00578045


Primary Contact:

Principal Investigator
Frits van Rhee, MD, PhD
University of Arkansas


Backup Contact:

N/A


Location Contact:

Little Rock, Arkansas 72205
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.